Duke researchers study Hepatitis C treatments
To find out why some racial and ethnic groups don’t respond well to these treatments, some Duke researchers compared the DNA sequences of patients.
Posted — UpdatedResearch shows East Asians respond best to the most common treatments, followed by Caucasians. African-Americans have the least success with treatment.
“We found a single change in one gene that doubles your chance of responding to treatment,” said Dr. Alex Thompson, of the Duke Clinical Research Institute and Division of Gastroenterology.
Thompson said the finding will change how patients are assessed for treatment. Researchers also said the findings will change how new Hepatitis C drugs are tested in clinical trials.
As a genotype 1 patient, Lasnier's hope for a cure was about 40 percent, but after undergoing treatment at Duke he was cured.
• Credits
Copyright 2024 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.